News & Events

WINSTON-SALEM, N.C., June 7, 2021 /PRNewswire/ — Javara, a leading Integrated Research Organization focused on improving clinical trial access and outcomes, announced today that it has appointed Brenda Reese, BSN, RN, as its first…

COVID-19 caused major change within the clinical research industry, including a significant shift toward decentralized trials and the implementation of many technological innovations. In this article with PharmaVOICE we hear from industry…

“Addressing the alarming gap in time-to-market primarily driven by prolonged patient accrual requires expanding awareness and access to clinical research as a care option within communities.” In this PharmaVOICE article, Javara…

From the perspective of COVID-19 clinical trials participant, John Reaves, there are two key strategies for improving minority participation in clinical research: heighten communication with patients and communities, and acknowledge, address,…

Javara CEO Jennifer Byrne kicked off this series by sharing the history of CRAACO and ways to bring clinical research closer to clinical care. In the next article, Acting FDA Commissioner Janet…

Health inequity is an expansive issue that plagues the entire country but is especially prevalent in our Winston-Salem community. Javara CEO Jennifer Byrne recently sat down with our partners at Innovation Quarter,…

In the fourth and final article of this Outsourcing Pharma series, Acting FDA Commissioner Janet Woodcock discusses ways to overcome barriers in the clinical research industry, including the integration of research…

In Part 2 of this series with Outsourcing Pharma, we hear from Javara CEO Jennifer Byrne about ways to bring clinical research and clinical care closer together by removing obstacles,…

Javara CEO Jennifer Byrne recently spoke with Outsourcing Pharma editor Jenni Spinner about the history and mission of CRAACO (Clinical Research as a Care Option) and the importance of all…